Popular artificial sweetener can weaken cancer treatment response; study finds a supplement that could help
A recent study reveals that sucralose consumption may hinder the effectiveness of cancer immunotherapy, particularly in melanoma and non-small cell lung cancer patients. Sucralose alters gut bacteria, leading to reduced arginine levels crucial for T cell function. Researchers suggest arginine supplementation as a potential solution to counteract sucralose's negative impact on immunotherapy outcomes.
A recent study reveals that sucralose consumption may hinder the effectiveness of cancer immunotherapy, particularly in melanoma and non-small cell lung cancer patients. Sucralose alters gut bacteria, leading to reduced arginine levels crucial for T cell function. Researchers suggest arginine supplementation as a potential solution to counteract sucralose's negative impact on immunotherapy outcomes.
